Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
From Fat to Function: Unpacking the Future of Precision Diabetology
In this episode of Rethinking Diabetes: A Weekly Review, we explore the evolving science behind GLP-1 receptor agonists, early Type 1 diabetes detection, and the rising significance of liver and adipose tissue in metabolic disease. From surprising cancer risk patterns to breakthroughs in continuous glucose monitoring and nocturnal blood pressure research, we unpack the latest evidence shaping the future of diabetology.
Bibliography
- Silverii GA et al. GLP-1 receptor agonists and cancer risk: a meta-analysis of RCTs. Diabetes Obes Metab. 2025;27(8):4454–4468. doi:10.1111/dom.16489
- Drygalski K. Pharmacological treatment of MASLD: current and future perspectives. Int J Mol Sci. 2025;26(13):6518. doi:10.3390/ijms26136518
- Mader JK et al. CGM to diagnose stage 2 type 1 diabetes. J Diabetes Sci Technol. 2025;19(4):1109–1127. doi:10.1177/19322968251333441
- Kuss O et al. Precision diabetology and mortality: meta-regression from CVOTs. Acta Diabetol. 2025;62(7):1073–1080. doi:10.1007/s00592-024-02425-8
- Do Cao C et al. Refractory follicular-derived thyroid cancer: ENDOCAN-TUTHYREF consensus. Ann Endocrinol (Paris). 2025;86(4):101735. doi:10.1016/j.ando.2025.101735
- Alzaid F et al. Immune cell–adipose tissue crosstalk in type 1 diabetes. Diabetologia. 2025;68(8):1616–1631. doi:10.1007/s00125-025-06437-z
- Parati G et al. Nocturnal blood pressure: ESH position paper. J Hypertens. 2025;43(8):1296–1318. doi:10.1097/HJH.0000000000004053
Lang A et al. Heat and diabetes: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2025;7(7):CD016289. doi:10.1002/14651858.CD016289
- Lasolle H et al. Refractory medullary thyroid cancer: ENDOCAN-TUTHYREF consensus. Ann Endocrinol (Paris). 2025;86(4):101733. doi:10.1016/j.ando.2025.101733
- Irace C et al. Enhancing type 2 diabetes care with CGM integration: Italian expert insights. Diabetes Metab Res Rev. 2025;41(5):e70059. doi:10.1002/dmrr.70059
-
